NewsBenzingaTruist Securities维持对Regeneron Pharmaceuticals的买入评级，将目标价上调至780美元 Truist Securities维持对Regeneron Pharmaceuticals的买入评级，将目标价上调至780美元 Benzinga 2026.10.07 17:05 (GMT+0) Open on Benzinga Other news Hewlett Packard Enterprise Stock Hits 52-Week Highs - Here's Why Citigroup Maintains Buy on Zscaler, Raises Price Target to $245 Citigroup Maintains Buy on ArriVent BioPharma, Lowers Price Target to $20 Spotify Takes Its Audiobook Push to More Than 180 Markets Citigroup Upgrades Flutter Entertainment to Buy, Lowers Price Target to $91 Lake Street Initiates Coverage On Fossil Group with Buy Rating, Announces Price Target of $10
